Kathryn A Phillips PhD
@kathrynp-phd.bsky.social
Professor Health Econ/Health Services Research @UCSF. Founder @UCSF_TRANSPERS, focused on effective/efficient/equitable implementation of emerging technologies. Founding Editor-in-Chief #HAScholar @Health_Affairs – OA journal emerging/global health policy. .. more
Professor Health Econ/Health Services Research @UCSF. Founder @UCSF_TRANSPERS, focused on effective/efficient/equitable implementation of emerging technologies. Founding Editor-in-Chief #HAScholar @Health_Affairs – OA journal emerging/global health policy.
Economics
44%
Biology
30%
A Threat to Evidence-Based Vaccine Policy and Public Health Security at the FDA | NEJM
Twelve former commissioners of the FDA express concern that the agency’s recent moves will undermine a regulatory model designed to ensure vaccine safety, effectiveness, and availability.
www.nejm.org
We need to listen to scientific experts and former FDA commissioners @robcaliff.bsky.social et al! A Threat to Evidence-Based Vaccine Policy and Public Health Security at the FDA | New England Journal of Medicine www.nejm.org/doi/full/10....
Top drug regulator Richard Pazdur set to leave the FDA
Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, raising concerns about agency turnover.
www.statnews.com
Ugh yet more turmoil at FDA. Only in this role one month!
Top drug regulator Richard Pazdur set to leave the FDA www.statnews.com/2025/12/02/r... via @statnews
Top drug regulator Richard Pazdur set to leave the FDA www.statnews.com/2025/12/02/r... via @statnews
Variation in US Commercial Health Plan Coverage Restrictions for Cell and Gene Therapies
This Viewpoint examines variations in US commercial health plan coverage restrictions for cell and gene therapies.
jamanetwork.com
Good detail re coverage variations from @tuftscevr.bsky.social @Jchambers241 . Variation in US Commercial Health Plan Coverage Restrictions for Cell and Gene Therapies jamanetwork.com/journals/jam...
Precision Medicine – making clinical decisions based on nuanced analyses of patients' personal characteristics, including genetics – has been "just around the corner" for >30 years. In my new Substack, I describe why AI is poised to deliver on the promise.
robertwachter.substack.com/p/can-ai-fin...
robertwachter.substack.com/p/can-ai-fin...
Can AI Finally Deliver on Precision Medicine’s Promise?
Yes, But Only If We Nail Both the Biology and Decision Support
robertwachter.substack.com
@bobwachter.bsky.social makes key points!
A few thoughts from me on that big GLP-1 news today!
www.pbs.org/newshour/sho...
www.pbs.org/newshour/sho...
The potential impact of lowering the cost of weight loss drugs
Millions of Americans will soon have direct access to popular weight-loss drugs at far lower prices than they pay now. That’s due to a deal announced between President Trump and pharmaceutical giants ...
www.pbs.org
@dusetzinas.bsky.social was clear and insightful as always!
Judge indefinitely bars Trump from fining UC over alleged discrimination
The Trump administration demanded UCLA pay $1.2 billion to restore frozen research funding and ensure eligibility for future funding after accusing the school of allowing antisemitism on campus.
share.google
Judge bars Trump from fining University of California over discrimination : NPR share.google/ZrIFMLciT7ct...
newsnetwork.mayoclinic.org
It's very early evidence but this could be game-changing role for #PrecisionMedicine. newsnetwork.mayoclinic.org/discussion/g...
I had the pleasure of curating a collection of articles for #HAScholar special collection on social policies & #health. The full collection is now freely available online, including articles on policy impacts, implementation barriers & more: academic.oup.com/healthaffair... @kathrynp-phd.bsky.social
Intersections of Social Policies and Health
A collection of articles published by Health Affairs Scholar. Edited by Rita Hamad.
This collection examines the effects of social policies on health; differen
academic.oup.com
@ritahamad.bsky.social is one of world's experts on this topic so very pleased that we could publish this collection! #HAScholar @Health_Affairs
Supreme Court Denies Request to Revisit Same-Sex Marriage Decision
www.nytimes.com
Supreme Court Denies Request to Revisit Same-Sex Marriage Decision www.nytimes.com/2025/11/10/u...
Reposted by Kathryn A. Phillips
Intersections of Social Policies and Health
A collection of articles published by Health Affairs Scholar. Edited by Rita Hamad.
This collection examines the effects of social policies on health; differen
academic.oup.com
I had the pleasure of curating a collection of articles for #HAScholar special collection on social policies & #health. The full collection is now freely available online, including articles on policy impacts, implementation barriers & more: academic.oup.com/healthaffair... @kathrynp-phd.bsky.social
Amid attacks on such work, NIH-led research links structural racism to increased heart disease
NIH-led research on structural racism was published Friday, even as the Trump administration has cancelled and discredited such work.
www.statnews.com
Amid attacks on such work, NIH-led research links structural racism to increased heart disease www.statnews.com/2025/10/31/s... via @statnews.com
Texans Make History with Passage of Proposition 14, Launching Nation’s Largest State-Funded Dementia Research Initiative
Texas voters approved funding the Dementia Prevention and Research Institute of Texas (DPRIT), the nation's largest state-funded dementia research initiative. OG image: press release
www.alz.org
Interesting that my home state would pass this! Texas voters approved funding the Dementia Prevention and Research Institute of Texas (DPRIT), the nation's largest state-funded dementia research initiative. OG image: press release www.alz.org/news/2025/te...
Excellent @PBS Frontline documentary provides insights to RFK Jr and his policies. The Rise of RFK Jr. undefined/documentary/the-rise-of-rfk-jr/
Reposted by Kathryn A. Phillips
The potential impact of lowering the cost of weight loss drugs
Millions of Americans will soon have direct access to popular weight-loss drugs at far lower prices than they pay now. That’s due to a deal announced between President Trump and pharmaceutical giants ...
www.pbs.org
A few thoughts from me on that big GLP-1 news today!
www.pbs.org/newshour/sho...
www.pbs.org/newshour/sho...
Reposted by Kathryn A. Phillips
Bob Wachter
@bobwachter.bsky.social
· Nov 6
Can AI Finally Deliver on Precision Medicine’s Promise?
Yes, But Only If We Nail Both the Biology and Decision Support
robertwachter.substack.com
Precision Medicine – making clinical decisions based on nuanced analyses of patients' personal characteristics, including genetics – has been "just around the corner" for >30 years. In my new Substack, I describe why AI is poised to deliver on the promise.
robertwachter.substack.com/p/can-ai-fin...
robertwachter.substack.com/p/can-ai-fin...
Cureus loses its impact factor
Web of Science announces "Editorial De-listing"
open.substack.com
2nd largest volume academic journal loses impact factor as delisted
open.substack.com/pub/journalo...
open.substack.com/pub/journalo...
Health Affairs Scholar Expands Its Reach with Fast-Tracked Peer Review and New Article Formats to Meet Today’s Needs
William B Feldman, MD, DPhil, MPH, Kathryn A Phillips, PhD, Donald E Metz; Health Affairs Scholar Expands Its Reach with Fast-Tracked Peer Review and New A
academic.oup.com
Congrats to @wbfeldman.bsky.social Health Affairs Scholar Editorial Fellow #HAScholar @Health_Affairs for leading this article! academic.oup.com/healthaffair...
Health Affairs Scholar Expands Its Reach with Fast-Tracked Peer Review and New Article Formats to Meet Today’s Needs
William B Feldman, MD, DPhil, MPH, Kathryn A Phillips, PhD, Donald E Metz; Health Affairs Scholar Expands Its Reach with Fast-Tracked Peer Review and New A
academic.oup.com
#HAScholar @Health_Affairs announces fast-track submission pathway and diverse and flexible article types that enable Health Affairs family to remain on cutting edge of evidence-based policy. Health Affairs Scholar Expands Its Reach to Meet Today’s Needs academic.oup.com/healthaffair...
Commercial Insurers Paid More For Procedures At Hospital Outpatient Departments Than At Ambulatory Surgical Centers | Health Affairs Journal
Site neutrality in payment practices has become a salient issue in the US health care debate, as rising prices have brought increased pressure for policy action. Although Medicare has received disprop...
www.healthaffairs.org
Excellent analysis that contributes to what we know beyond Medicare on this topic. Commercial Insurers Paid More For Procedures At Hospital Outpatient Departments Than At Ambulatory Surgical Centers | Health Affairs www.healthaffairs.org/doi/10.1377/...
The Make American Healthy Again Strategy Report
This Viewpoint discusses the deficiencies of the Make America Healthy Again Commission’s strategy report and proposes known evidence-based interventions to address chronic diseases in children.
jamanetwork.com
Glad to see this from my former UCSF colleague Peter Lurie.The Make American Healthy Again Strategy Report url: jamanetwork.com/journals/jam...
Reposted by Kathryn A. Phillips
ANSIRH
@ansirh.bsky.social
· Oct 25
Abortion bans deepen economic inequality.
Abortion bans deepen economic inequality.
Abortion bans deepen economic inequality.
Abortion bans deepen economic inequality.
Abortion bans deepen economic inequality.
The relationship between state-level abortion policy and maternal mortality in the United States: a scoping review
AbstractIntroduction. The United States has a high rate of maternal mortality compared to similar countries. Following the overturning of Roe v. Wade and f
academic.oup.com
Editors Choice! #HAScholar @healthAffairs Relationship between state-level abortion policy and maternal mortality in the United States: a scoping review academic.oup.com/healthaffair...
Models attempting to quantify the relationship between drug development and financial return are missing a key element: the effect on post-approval research
Abstract. Changes in biopharmaceutical policy, specifically the Inflation Reduction Act (IRA), introduced administrative drug price setting in the U.S., pr
academic.oup.com
New in #HAScholar @Health_Affairs Models attempting to quantify the relationship between drug development and financial return are missing a key element: the effect on post-approval research academic.oup.com/healthaffair...
Reposted by Kathryn A. Phillips, Ruairidh Milne
Eric Topol
@erictopol.bsky.social
· Oct 21
The Largest Study of a Multi-Cancer Early Detection Blood Test
Reviewing the new data and the "liquid biopsy" field
erictopol.substack.com
What did the largest trial of an early detection of cancer blood test show?
erictopol.substack.com/p/the-larges...
erictopol.substack.com/p/the-larges...
Social Policies as Determinants of Health: New Evidence, Ongoing Challenges, and Future Pathways
Abstract. Despite acknowledgment that social and economic policies fundamentally shape health, persistent geographic and sociodemographic inequities in the
academic.oup.com
Timely overview of important topic by @ritahamad.bsky.social #HAScholar @Health_Affairs. Social Policies as Determinants of Health: New Evidence, Ongoing Challenges, and Future Pathways url: academic.oup.com/healthaffair...
Validate User
academic.oup.com
2 leading experts on scientific publication & former Editors-in-Chief @JAMA published commentary in #HAScholar @Health_Affairs on Administration's focus on “gold standard science” – its opportunities but also its challenges. academic.oup.com/healthaffair...
Drummond was great mentor to me...continuing his efforts now! Commentary from 2 experts on scientific publication & former Editors-in-Chief @JAMA in #HAScholar @Health_Affairs on Administration's focus on “gold standard science” – opportunities but also challenges. academic.oup.com/healthaffair...
M.I.T. Rejects a White House Offer for Special Funding Treatment
www.nytimes.com
M.I.T. Rejects a White House Offer for Special Funding Treatment www.nytimes.com/2025/10/10/u...
How to make one line in the FDA Commissioner’s new drug review program into a force for affordable access for patients -- a new Health Affairs Scholar paper by ICER President and CEO Sarah Emond and Chief Scientific Officer Dan Ollendorf: tinyurl.com/32bexcd9
How to make one line in the FDA Commissioner's new drug review program into a force for affordable access for patients
Abstract. The FDA Commissioner's new National Priority Voucher program seeks to accelerate drug approvals for products meeting certain criteria. Interestin
tinyurl.com
Thrilled to publish this in #HAScholar @ Health Affairs. "So much is changing in the drug approval and pricing space, and in order to ensure affordability for patients and society,
policymakers should pay close attention to the merits of a U.S.-based value assessment approach
policymakers should pay close attention to the merits of a U.S.-based value assessment approach